
pmid: 23104253
pmc: PMC6275752
AbstractThe purpose of this study was to evaluate the influence of bone marrow-mesenchymal stem cells (BM-MSC) and exogenously added cytokines on the proliferation, primitive cell subpopulation maintenance (including the c-kit+ marker) and clonogenic capacity of hematopoietic stem cells (HSC). BM-MSC were collected from volunteer donors, isolated and characterized. Umbilical cord blood (UCB) samples were collected from healthy full-term deliveries. UCB-CD34+ cells were cultured in the presence or absence of BM-MSC and/or cytokines for 3 and 7 days. CD34+ cell proliferation was evaluated using the CSFE method and cell phenotype was determined by CD34, c-kit, CD33, CD38, HLA-DR, cyCD22 and cyCD3 detection. Cell clonogenic ability was also assessed. Exogenously added SCF, TPO and FLT3L increasedCD34+ cell proliferation in the presence or absence of BM-MSC, but with concomitant cell differentiation. Without any added cytokines, BM-MSC are able to increase the percentage of primitive progenitors as evaluated by c-kit expression and CFU-GEMM increase. Interestingly, this latter effect was dependent on both cell-cell interactions and secreted factors. A 7-day co-culture period will be optimal for obtaining an increased primitive HSC level. Including c-kit as a marker for primitive phenotype evaluation has shown the relevance of BM-MSC and their secreted factors on UCB-HSC stemness function. This effect could be dissociated from that of the addition of exogenous cytokines, which induced cellular differentiation instead.
Pulmonary and Respiratory Medicine, Cell biology, Immunology, Gene Expression, Antigens, CD34, Bone Marrow Cells, Cell Communication, Gene, Immunophenotyping, Health Sciences, In vivo, Genetics, Humans, Neonatal Lung Development and Respiratory Morbidity, Biology, Myeloid Progenitor Cells, Cell Proliferation, Mesenchymal stem cell, Stem Cell Factor, Stem cell, FOS: Clinical medicine, Membrane Proteins, Cell Differentiation, Mesenchymal Stem Cells, Cord blood, Hematology, Fetal Blood, Hematopoietic Stem Cells, Coculture Techniques, Ex vivo, Proto-Oncogene Proteins c-kit, Haematopoiesis, Phenotype, Thrombopoietin, Multipotent Mesenchymal Stem Cells, FOS: Biological sciences, Medicine, Hematopoietic Stem Cell Biology, CD34, Biomarkers, Research Article, Signal Transduction
Pulmonary and Respiratory Medicine, Cell biology, Immunology, Gene Expression, Antigens, CD34, Bone Marrow Cells, Cell Communication, Gene, Immunophenotyping, Health Sciences, In vivo, Genetics, Humans, Neonatal Lung Development and Respiratory Morbidity, Biology, Myeloid Progenitor Cells, Cell Proliferation, Mesenchymal stem cell, Stem Cell Factor, Stem cell, FOS: Clinical medicine, Membrane Proteins, Cell Differentiation, Mesenchymal Stem Cells, Cord blood, Hematology, Fetal Blood, Hematopoietic Stem Cells, Coculture Techniques, Ex vivo, Proto-Oncogene Proteins c-kit, Haematopoiesis, Phenotype, Thrombopoietin, Multipotent Mesenchymal Stem Cells, FOS: Biological sciences, Medicine, Hematopoietic Stem Cell Biology, CD34, Biomarkers, Research Article, Signal Transduction
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 33 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
